The Gold Standard In Cancer Staging
Links shared publicly online about this topic.
- 1,625total visits
The Gold Standard In Cancer Staging
View full resource at medicalnewstoday.com
Tags: Cancer, Cancer Staging, Healthcare, Physician
Most Recently Shared on November 5, 2009 at 12:15 pm By:
The Gold Standard In Cancer Staging: Physicians and health care professionals around the world need a tool to f.. http://bit.ly/4aBFU8
Also Shared By:
Breast Tumor Cell Detection at Single Cell resolution Using Electrochemical Impedance Technique - Lab on a Chip (RSC Publishing)
pubs.rsc.org — “Gold micro-electrodes with various diameters (25, 50, 75, 100 and 250 µm) were manufactured using standard micro-fabrication techniques and optimized for breast cancer tumor cell, (MCF-7) detection with single cell resolution. For cell capture, anti-EpCAM was immobilized on 11-mercaptoundecanoic acid (11-MUA” View full resource at pubs.rsc.org
Most Recently Shared on March 16, 2012 at 10:46 pm By:
Breast Tumor Cell Detection at Single Cell resolution Using Electrochemical Impedance Technique: Lab Chip, 2012,... http://t.co/hReYSLwB
Peregrine's cancer drug data disappoints; shares plunge - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Peregrine Pharmaceuticals said an independent assessment of data from a mid-stage trial showed unexpectedly high progression-free survival rates in lung cancer patients receiving standard chemotherapy, ...” View full resource at finance.yahoo.com
Most Recently Shared on March 9, 2012 at 9:54 pm By:
Peregrine's cancer drug data disappoints; shares plunge: Peregrine Pharmaceuticals said an independent assessmen... http://t.co/6xfYZQtG
New Drug Combination Destroys Pancreatic Cancer Cells
medrounds.org — “Find a doctor with Verified Reviews, the gold standard for reviews. Publisher of Verified Doctor Reviews from Verified Patient Reviews and medical books, health books, and other educational resources.” View full resource at medrounds.org
Most Recently Shared on March 1, 2012 at 9:34 am By:
Andrew Doan, MD, PhD Ophthalmologist, Physician, PhD, and Doctor
New Drug Combination Destroys Pancreatic Cancer Cells http://t.co/VKAfXbRJ
The UNC Health Care System Receives CEO Cancer Gold Standard(TM) Accreditation - MarketWatch
marketwatch.com — “The UNC Health Care System Receives CEO Cancer Gold Standard(TM) Accreditation - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on January 4, 2012 at 1:11 pm By:
The UNC Health Care System Receives CEO Cancer Gold Standard(TM) Accreditation: CARY, NC, Jan 04, 2012 (BUSINESS... http://t.co/3Ixo7Mlv
BRCA1 gene mutation associated with neoadjuvant chemotherapy
medicalxpress.com — “Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) – the disappearance of all evidence of disease from the breast tissue and lymph nodes – regardless of disease stage after standard neoadjuvent chemotherapy, according to ...” View full resource at medicalxpress.com
Most Recently Shared on September 6, 2011 at 8:37 pm By:
BRCA1 gene mutation associated with neoadjuvant chemotherapy http://t.co/VnLszOU
CT Scans Can Be Unreliable for Lung Cancer Detection
articles.mercola.com — “New research reveals that CT scans, the so-called "gold-standard" test for measuring lung cancer growth may be highly inaccurate.” View full resource at articles.mercola.com
Most Recently Shared on August 6, 2011 at 6:05 pm By:
Dr. Mercola Doctor, Family Medicine Doctor, and Physician
New #research reveals this "gold-standard" test for measuring #cancer growth may be highly inaccurate. http://ow.ly/5VIQD
CT Scans Can Be Unreliable for Lung Cancer Detection
articles.mercola.com — “New research reveals that CT scans, the so-called "gold-standard" test for measuring lung cancer growth may be highly inaccurate.” View full resource at articles.mercola.com
Most Recently Shared on August 6, 2011 at 12:48 pm By:
Fred Bloem MD Integrative Physician, Physician, Doctor, and CAM
Lung Cancer Scans Can be Unreliable #health http://t.co/89JZYGo
A New Prostate Cancer Test | Men's Health News
news.menshealth.com — “By combining a new urine test with the gold-standard PSA (prostate-specific antigen) tests, doctors can have a better picture of if you might need a biopsy.” View full resource at news.menshealth.com
Most Recently Shared on August 5, 2011 at 2:55 am By:
Men's Health Mag Health Magazine
There’s FINALLY a urine test for prostate cancer. What you need to know: http://ow.ly/5VlHV
Tumor marker, endoscopic ultrasound more likely to detect stage 1 pancreatic cancer
news-medical.net — “Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.” View full resource at news-medical.net
Most Recently Shared on July 26, 2011 at 6:25 am By:
Tumor marker, endoscopic ultrasound more likely to detect stage 1 pancreatic cancer: Researchers from New Englan... http://bit.ly/p1Y8VH
Study examines screening for pancreatic cancer in high-risk populations
medicalxpress.com — “Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection. The study appears ...” View full resource at medicalxpress.com
Most Recently Shared on July 25, 2011 at 7:06 pm By:
Study examines screening for pancreatic cancer in high-risk populations http://bit.ly/omaJhr
Interim Safety Data Compared in Ixabepilone TITAN Trial
onclive.com — “Researchers are continuing to explore whether ixabepilone (Ixempra) is a better choice as adjuvant chemotherapy for patients with early-stage, triple-negative breast cancer than the standard paclitaxel (Taxol).” View full resource at onclive.com
Most Recently Shared on July 18, 2011 at 5:22 pm By:
Interim Safety Data Compared in Ixabepilone TNBC TITAN Trial http://t.co/JSkXO8N #breastcancer #tnbc
Gold Standard Diagnostics Signs Distribution Agreement With Fujirebio Diagnostics | IVD Technology
ivdtechnology.com — “Gold Standard Diagnostics Corp. announced the execution of an agreement with Fujirebio Diagnostics to distribute their proprietary Multi-Constituent Tumor Marker Control in the United States. Fujirebio Diagnostics, best known in the U.S. market as the developers of the CA125 ovarian cancer marker, has several patents on biomarkers for various disease states, but is primarily focused on oncology markers.” View full resource at ivdtechnology.com
Most Recently Shared on July 13, 2011 at 7:00 pm By:
IVD Technology Health Magazine
Gold Standard Diagnostics Signs Distribution Agreement With Fujirebio Diagnostics http://tinyurl.com/6b2lq25
Erbitux meets gold standard in rectal cancer | InPharm
inpharm.com — “Rectal cancer trials of Merck Serono’s Erbitux have shown improved overall survival, a gold standard measure in oncology trials” View full resource at inpharm.com
Most Recently Shared on June 7, 2011 at 8:09 am By:
Pharmafocus Pharma and Health News
Erbitux meets gold standard in rectal cancer http://goo.gl/fb/QrKXk
Study Confirms Long-Lasting Anticancer Benefit Of Zoledronic Acid For Women With Early-Stage Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “Women with early-stage hormone receptor-sensitive breast cancer* given zoledronic acid, a bone strengthening drug, in addition to standard hormone therapy for 3 years following surgery are at significantly (32%) less risk of their cancer returning, and the effect is long lasting, according to the long-term results of the landmark Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) published Online First in The Lancet Oncology...” View full resource at qualitypointtech.net
Most Recently Shared on June 4, 2011 at 1:45 am By:
Study Confirms Long-Lasting Anticancer Benefit Of Zoledronic Acid For Women With Early-Stage Breast Cancer: Women ... http://bit.ly/movSOx
Roche’s Tarceva Stalls Lung Cancer With Gene Mutation in Late-Stage Study - Bloomberg
bloomberg.com — “Roche Holding AG , the world’s biggest maker of cancer drugs, said its Tarceva medicine kept a form of advanced lung tumor at bay for almost twice as long as standard treatment in a late-stage clinical trial.” View full resource at bloomberg.com
Most Recently Shared on June 3, 2011 at 2:49 pm By:
Jack A. Roth, M.D. Surgeon, Physician, and Doctor
Erlotinib (Tarceva) prolongs survival more than chemotherapy as initial treatment for lung cancer with EGFR mutation http://bloom.bg/jbhjhS
Advertisement
MNT Cancer News
@mnt_cancer
The Gold Standard In Cancer Staging: Physicians and health care professionals around the world need a tool to f.. http://bit.ly/4aBFU8
1 year ago...